various ATBC acetyl tributyl citrate in Congo

various ATBC acetyl tributyl citrate in Congo

efficient analysis of toxicity and mechanisms of acetyl

various ATBC acetyl tributyl citrate in Congo

what is acetyl tributyl citrate / ATBC? longchang chemical

various ATBC acetyl tributyl citrate in Congo

acetyl tributyl citrate (ATBC) chemical supplier manufacturer

various ATBC acetyl tributyl citrate in Congo

acetyl tributyl citrate (ATBC) manufacturers and suppliers

various ATBC acetyl tributyl citrate in Congo

pharmacokinetic properties of acetyl tributyl citrate, a

various ATBC acetyl tributyl citrate in Congo
  • Does ATBC stably interact with target genes?
  • To substantiate our analytical findings, we conducted a molecular docking study, which unveiled a pronounced affinity between ATBC and the five core target genes—AR, HDAC1, CREBBP, STAT3, and PARP1.This discovery suggests that ATBC has the capacity to spontaneously and stably interact with these target genes.
  • Does ATBC pose a clinical risk?
  • Current literature does not clearly indicate that ATBC presents a clinical risk. However, as a plasticizer extensively utilized in daily life, ATBC may still present several potential risks due to prolonged and significant human exposure.
  • Do cellular senescence core targets bind to ATBC?
  • Notably, all four cellular senescence core target proteins showed strong binding to ATBC with binding energies of < −5 kcal/mol, suggesting that ATBC and each of the core targets can spontaneously bind, and also suggesting that they play an important role in the molecular mechanism of ATBC-induced senescence. 3.8.
  • What are core targets of ATBC-induced senescence?
  • A comprehensive analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways revealed that core targets of ATBC-induced senescence were predominantly enriched in pathways related to the positive regulation of cell proliferation, telomere shortening, cancer, and cellular senescence.
  • What is the no-observed-adverse-effect level (NOAEL) for ATBC vs DEHP?
  • The European Food Safety Authority (EFSA) reported a chronic toxicological no-observed-adverse-effect level (NOAEL) of 300 mg-kg-1-bw-1 for ATBC, whereas the NOAEL for DEHP was 4.8 mg-kg-1-bw-1 (Rasmussen et al., 2017). Current literature does not clearly indicate that ATBC presents a clinical risk.